About
David Grainger is a British life-sciences venture capitalist and scientist best known as a co-founder/partner of Medicxi after earlier work with Index Ventures' life-sciences practice. Before venture investing, he was a Cambridge researcher and founder/operator of biotech companies including FingerPrint Diagnostics and Funxional Therapeutics. He has also served as CEO of Methuselah Health, linking him directly to longevity-focused drug development.
Areas of interest
biotechdrug discoverylife sciences venture capitalcardiometabolic diseaseobesitymetabolic diseaselongevitytranslational medicine